Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort.
Marie PoulettyCharlotte BoroccoNaim OuldaliMarion CaserisRomain BasmaciNoémie LachaumePhilippe BensaidSamia PichardHanane KouiderGuillaume MorelleIrina CraiuCorinne PondarreAnna DehoArielle MaroniMehdi OualhaZahir AmouraJulien HarocheJuliette ChommelouxFanny BajolleConstance BeylerStéphane BonacorsiGuislaine CarcelainIsabelle Kone-PautBrigitte Bader-MeunierAlbert FayeUlrich MeinzerCaroline GaleottiIsabelle MelkiPublished in: Annals of the rheumatic diseases (2020)
Kawa-COVID-19 likely represents a new systemic inflammatory syndrome temporally associated with SARS-CoV-2 infection in children. Further prospective international studies are necessary to confirm these findings and better understand the pathophysiology of Kawa-COVID-19. Trial registration number NCT02377245.